Armata Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 04:00 pm EST
Armata Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 31.16 million compared to USD 8.61 million a year ago. Basic loss per share from continuing operations was USD 0.86 compared to USD 0.24 a year ago.
For the nine months, net loss was USD 49.2 million compared to USD 26.6 million a year ago. Basic loss per share from continuing operations was USD 1.36 compared to USD 0.79 a year ago.